Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605942 · ClinicalTrials.gov registry record · Phase 1
A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery
A Phase 1 study, sponsored by Allergan.
- Terminated
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01605942: Clinical Trial Phase 1 study, sponsored by Allergan.
NCT01605942 is a Phase 1 study that was terminated before completion, run by Allergan. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01605942, a Phase 1 study, was terminated before completion, sponsored by Allergan.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This is a safety and efficacy study of a Dexamethasone Drug Delivery System for anterior segment inflammation and pain following cataract extraction with lens implantation.
Primary Outcome
The anterior chamber is the area in front of the iris (colored part of the eye). Inflammation is measured on a scale ranging from 0 (best) to 8 (worst).
Interventions
- DRUG Dexamethasone Drug Delivery System
- DRUG Placebo Drug Delivery System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-06 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Why NCT01605942 stopped before completion
NCT01605942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone Drug Delivery System is the first listed.
NCT01605942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01605942 about?
NCT01605942 is a clinical study titled "A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery". This is a safety and efficacy study of a Dexamethasone Drug Delivery System for anterior segment inflammation and pain following cataract extraction with lens implantation.
What is the current status of trial NCT01605942?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2012-06. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01605942?
The interventions under investigation include: Dexamethasone Drug Delivery System (DRUG), Placebo Drug Delivery System (DRUG).
Who is sponsoring clinical trial NCT01605942?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01605942's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia